QUANEX BUILDING PRODUCTS (NX) Fundamental Analysis & Valuation

NYSE:NX • US7476191041

Current stock price

17.66 USD
-0.01 (-0.06%)
Last:

This NX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NX Profitability Analysis

1.1 Basic Checks

  • In the past year NX was profitable.
  • NX had a positive operating cash flow in the past year.
  • NX had positive earnings in 4 of the past 5 years.
  • In the past 5 years NX always reported a positive cash flow from operatings.
NX Yearly Net Income VS EBIT VS OCF VS FCFNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -12.13%, NX is doing worse than 78.57% of the companies in the same industry.
  • NX's Return On Equity of -32.86% is on the low side compared to the rest of the industry. NX is outperformed by 76.19% of its industry peers.
  • NX's Return On Invested Capital of 5.46% is on the low side compared to the rest of the industry. NX is outperformed by 66.67% of its industry peers.
  • NX had an Average Return On Invested Capital over the past 3 years of 6.69%. This is significantly below the industry average of 11.91%.
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROIC 5.46%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
NX Yearly ROA, ROE, ROICNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.52%, NX is doing worse than 61.90% of the companies in the same industry.
  • In the last couple of years the Operating Margin of NX has remained more or less at the same level.
  • The Gross Margin of NX (27.37%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NX has grown nicely.
Industry RankSector Rank
OM 6.52%
PM (TTM) N/A
GM 27.37%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
NX Yearly Profit, Operating, Gross MarginsNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NX is destroying value.
  • NX has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NX has more shares outstanding
  • NX has a worse debt/assets ratio than last year.
NX Yearly Shares OutstandingNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NX Yearly Total Debt VS Total AssetsNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • NX has an Altman-Z score of 1.83. This is not the best score and indicates that NX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.83, NX is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
  • NX has a debt to FCF ratio of 7.45. This is a slightly negative value and a sign of low solvency as NX would need 7.45 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.45, NX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.93 indicates that NX is somewhat dependend on debt financing.
  • NX has a worse Debt to Equity ratio (0.93) than 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Altman-Z 1.83
ROIC/WACC0.54
WACC10.05%
NX Yearly LT Debt VS Equity VS FCFNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • NX has a Current Ratio of 2.31. This indicates that NX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of NX (2.31) is better than 64.29% of its industry peers.
  • A Quick Ratio of 1.21 indicates that NX should not have too much problems paying its short term obligations.
  • NX has a Quick ratio of 1.21. This is in the better half of the industry: NX outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.21
NX Yearly Current Assets VS Current LiabilitesNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NX Growth Analysis

3.1 Past

  • NX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.65%.
  • Measured over the past years, NX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.25% on average per year.
  • The Revenue has grown by 28.35% in the past year. This is a very strong growth!
  • Measured over the past years, NX shows a quite strong growth in Revenue. The Revenue has been growing by 16.63% on average per year.
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.82% on average over the next years.
  • The Revenue is expected to grow by 1.75% on average over the next years.
EPS Next Y-6.48%
EPS Next 2Y3.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.23%
Revenue Next 2Y1.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NX Yearly Revenue VS EstimatesNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NX Yearly EPS VS EstimatesNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. NX Valuation Analysis

4.1 Price/Earnings Ratio

  • NX is valuated reasonably with a Price/Earnings ratio of 8.37.
  • 100.00% of the companies in the same industry are more expensive than NX, based on the Price/Earnings ratio.
  • NX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.11.
  • The Price/Forward Earnings ratio is 7.09, which indicates a rather cheap valuation of NX.
  • 100.00% of the companies in the same industry are more expensive than NX, based on the Price/Forward Earnings ratio.
  • NX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.12.
Industry RankSector Rank
PE 8.37
Fwd PE 7.09
NX Price Earnings VS Forward Price EarningsNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NX is cheaper than 90.48% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NX indicates a rather cheap valuation: NX is cheaper than 97.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.55
EV/EBITDA 6.52
NX Per share dataNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y3.82%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.88%, NX has a reasonable but not impressive dividend return.
  • NX's Dividend Yield is rather good when compared to the industry average which is at 0.75. NX pays more dividend than 88.10% of the companies in the same industry.
  • NX's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.88%

5.2 History

  • The dividend of NX has a limited annual growth rate of 0.08%.
  • NX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.08%
Div Incr Years0
Div Non Decr Years15
NX Yearly Dividends per shareNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • NX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of NX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-6.13%
EPS Next 2Y3.82%
EPS Next 3YN/A
NX Yearly Income VS Free CF VS DividendNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

NX Fundamentals: All Metrics, Ratios and Statistics

QUANEX BUILDING PRODUCTS

NYSE:NX (3/18/2026, 10:18:11 AM)

17.66

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-05
Earnings (Next)06-03
Inst Owners108.05%
Inst Owner Change3.44%
Ins Owners1.26%
Ins Owner Change10.95%
Market Cap811.30M
Revenue(TTM)1.85B
Net Income(TTM)-239.99M
Analysts86
Price Target28.56 (61.72%)
Short Float %3.9%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 1.88%
Yearly Dividend0.32
Dividend Growth(5Y)0.08%
DP-6.13%
Div Incr Years0
Div Non Decr Years15
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.79%
Min EPS beat(2)56.47%
Max EPS beat(2)83.12%
EPS beat(4)3
Avg EPS beat(4)35.6%
Min EPS beat(4)-20.49%
Max EPS beat(4)83.12%
EPS beat(8)7
Avg EPS beat(8)494.92%
EPS beat(12)11
Avg EPS beat(12)346.29%
EPS beat(16)14
Avg EPS beat(16)266.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-2.2%
Max Revenue beat(4)1.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)4
Avg Revenue beat(12)-0.88%
Revenue beat(16)7
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-7.82%
EPS NQ rev (3m)-12.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.88%
Revenue NQ rev (1m)3.46%
Revenue NQ rev (3m)3.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.64%
Valuation
Industry RankSector Rank
PE 8.37
Fwd PE 7.09
P/S 0.44
P/FCF 8.55
P/OCF 5.16
P/B 1.11
P/tB N/A
EV/EBITDA 6.52
EPS(TTM)2.11
EY11.95%
EPS(NY)2.49
Fwd EY14.1%
FCF(TTM)2.07
FCFY11.7%
OCF(TTM)3.42
OCFY19.38%
SpS40.2
BVpS15.9
TBVpS-1.95
PEG (NY)N/A
PEG (5Y)0.63
Graham Number27.47
Profitability
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROCE 6.95%
ROIC 5.46%
ROICexc 5.67%
ROICexgc 11.13%
OM 6.52%
PM (TTM) N/A
GM 27.37%
FCFM 5.14%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
ROICexc(3y)7.19%
ROICexc(5y)10.09%
ROICexgc(3y)13.35%
ROICexgc(5y)17.83%
ROCE(3y)8.51%
ROCE(5y)11.84%
ROICexgc growth 3Y-23.91%
ROICexgc growth 5Y-6.21%
ROICexc growth 3Y-29.51%
ROICexc growth 5Y-7.67%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Debt/EBITDA 3.04
Cap/Depr 60.52%
Cap/Sales 3.37%
Interest Coverage 250
Cash Conversion 70.37%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.21
Altman-Z 1.83
F-Score5
WACC10.05%
ROIC/WACC0.54
Cap/Depr(3y)69.75%
Cap/Depr(5y)69.6%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
EPS Next Y-6.48%
EPS Next 2Y3.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%
Revenue Next Year1.23%
Revenue Next 2Y1.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y132.01%
EBIT growth 3Y2.12%
EBIT growth 5Y16.22%
EBIT Next Year37.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.45%
FCF growth 3Y16.4%
FCF growth 5Y6.37%
OCF growth 1Y6.38%
OCF growth 3Y18.95%
OCF growth 5Y10.34%

QUANEX BUILDING PRODUCTS / NX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QUANEX BUILDING PRODUCTS?

ChartMill assigns a fundamental rating of 4 / 10 to NX.


Can you provide the valuation status for QUANEX BUILDING PRODUCTS?

ChartMill assigns a valuation rating of 7 / 10 to QUANEX BUILDING PRODUCTS (NX). This can be considered as Undervalued.


Can you provide the profitability details for QUANEX BUILDING PRODUCTS?

QUANEX BUILDING PRODUCTS (NX) has a profitability rating of 3 / 10.


How financially healthy is QUANEX BUILDING PRODUCTS?

The financial health rating of QUANEX BUILDING PRODUCTS (NX) is 3 / 10.


What is the earnings growth outlook for QUANEX BUILDING PRODUCTS?

The Earnings per Share (EPS) of QUANEX BUILDING PRODUCTS (NX) is expected to decline by -6.48% in the next year.